Form 8-K - Current report:
SEC Accession No. 0001493152-23-005722
Filing Date
2023-02-22
Accepted
2023-02-22 06:06:31
Documents
13
Period of Report
2023-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43614
2 ex10-1.htm EX-10.1 36703
  Complete submission text file 0001493152-23-005722.txt   264561

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT shph-20230215.xsd EX-101.SCH 3242
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT shph-20230215_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT shph-20230215_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3625
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 23650439
SIC: 2834 Pharmaceutical Preparations